Platelet-activating Factor Receptor Activation
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system results in neuronal apoptosis. Activated HIV-1-infected monocytes secrete high levels of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) and the phospholipid mediator platelet-activating factor (PAF)....
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 1998-07, Vol.273 (28), p.17660-17664 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system results in neuronal apoptosis. Activated
HIV-1-infected monocytes secrete high levels of the proinflammatory cytokine tumor necrosis factor-α (TNF-α) and the phospholipid
mediator platelet-activating factor (PAF). TNF-α and PAF are elevated in the central nervous system of patients with HIV-1-associated
dementia. We now demonstrate that conditioned media from activated HIV-1-infected monocytes induces neuronal apoptosis, which
can be prevented by co-incubation with PAF acetylhydrolase, the enzyme that catabolizes PAF in the central nervous system.
Preceding apoptosis is a TNF-α-induced increase in neuronal ceramide levels. TNF-α-mediated neuronal apoptosis can also be
blocked by co-incubation with PAF acetylhydrolase, or a PAF receptor antagonist. Blocking pathologic activation of PAF receptors
may therefore be a pivotal step in the treatment of HIV-1-associated dementia. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.273.28.17660 |